Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Americas

      AbbVie teams with pharma firm to develop cancer drug

      Americas
      AbbVie Inc. could pay for a pharmaceutical firm in Massachusetts more than $800 million in a collaboration on a potential treatment for cancer. Cambridge,...

      Knight Therapeutics acquires Orphan Canada

      Americas
      Knight Therapeutics, a leading Canadian specialty pharmaceutical company, has entered into an agreement of purchase of assets with Orphan Canada (orphan) related to the...

      Antares Pharma to Participate at the Morgan Stanley Healthcare Conference

      Americas
      Antares Pharma, Inc. today announced that Eamonn P. Hobbs, President and Chief Executive Officer and Robert F. Apple, Chief Financial Officer and President of...

      Luye Pharma Acquired 57.98% Stake of Beijing Jialin Pharmaceutical

      Americas
      The board of directors of Luye Pharma Group Ltd., announced yesterday that the Company had entered into an agreement to purchase 57.98% stake of...

      Luye Pharma Acquired 57.98% Stake of Beijing Jialin Pharmaceutical

      Americas
      The board of directors of Luye Pharma Group Ltd., announced yesterday that the Company had entered into an agreement to purchase 57.98% stake of...

      Boston Strategics begins Phase I trial of anti-cancer agent to treat haematologic malignancies

      Americas
      Boston Strategics (BSC) has started a Phase I clinical trial of Fujifilm's anti-cancer agent FF-10501 in the US to treat patients with advanced haematologic...

      Exelixis’ Phase III prostate cancer trial of cabozantinib fails to meet primary endpoint

      Americas
      US-based biopharmaceutical firm Exelixis has reported disappointing top-line results from the final analysis of COMET-1, the Phase III trial of cabozantinib in men with...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.